MTLS MATERIALISE NV

Nasdaq materialise.com


$ 6.06 $ 0.14 (2.38 %)    

Tuesday, 14-Oct-2025 15:58:30 EDT
QQQ $ 604.16 $ 0.00 (0 %)
DIA $ 465.25 $ 0.00 (0 %)
SPY $ 667.23 $ 0.00 (0 %)
TLT $ 90.98 $ 0.00 (0 %)
GLD $ 384.99 $ 0.00 (0 %)
$ 6.03
$ 5.83
$ 6.03 x 1,100
$ 6.50 x 70
-- - --
$ 3.93 - $ 9.69
197,871
na
356.18M
$ 1.40
$ 25.61
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 materialise-lowers-fy2025-sales-guidance-from-28817m-30418m-to-28393m-29971m-vs-27867m-est

Materialise (NASDAQ:MTLS) lowers FY2025 sales outlook from $288.17 million-$304.18 million to $283.93 million-$299.71 million v...

 materialise-q1-eps-001-beats-004-estimate-sales-7179m-beat-6310m-estimate

Materialise (NASDAQ:MTLS) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.04) b...

 palantir-rally-loses-steam-walmart-outlook-disappoints-whats-driving-markets-thursday

Stocks tumbled Thursday, with all major indices in the red, one day after the S&P 500 notched another all-time high in Wedn...

 materialise-anticipates--difficult-macroeconomic-environment-to-persist-throughout-2025-specifically-in-european-industrial-sector

"For calendar year 2025, we expect our three reporting segments to evolve at a different pace. We anticipate the strongest ...

 materialise-reiterated-fy24-revenue-of-265m-275m-vs-26853m-est

2024 GuidanceMrs. de Vet-Veithen concluded, "The consistently strong operational performance of our business segments throu...

 correction-reported-jul-31-materialise-q2-gaap-eps-007-beats-005-estimate-sales-7365m-beat-7310m-estimate

Materialise (NASDAQ:MTLS) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.05 by ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION